about
Clinicopathologic and prognostic significance of c-MYC copy number gain in lung adenocarcinomas.The DNA double-strand break response is abnormal in myeloblasts from patients with therapy-related acute myeloid leukemia.The Dual Roles of MYC in Genomic Instability and Cancer ChemoresistanceRole of Ku70 in deubiquitination of Mcl-1 and suppression of apoptosis.Myc-dependent genome instability and lifespan in Drosophila.Identification of synthetic lethality of PRKDC in MYC-dependent human cancers by pooled shRNA screening.c-MYC is a radiosensitive locus in human breast cellsCathepsin L suppression increases the radiosensitivity of human glioma U251 cells via G2/M cell cycle arrest and DNA damage.Immunohistochemical, genetic and epigenetic profiles of hereditary and triple negative breast cancers. Relevance in personalized medicineEffects of Low-Dose Bisphenol A on DNA Damage and Proliferation of Breast Cells: The Role of c-MycA new phosphorylated form of Ku70 identified in resistant leukemic cells confers fast but unfaithful DNA repair in cancer cell lines.The Role of miR-34a in Tritiated Water Toxicity in Human Umbilical Vein Endothelial Cells.Cancer subclonal genetic architecture as a key to personalized medicine.The involvement of c-Myc in the DNA double-strand break repair via regulating radiation-induced phosphorylation of ATM and DNA-PKcs activity.New Insight into microRNA Functions in Cancer: Oncogene-microRNA-Tumor Suppressor Gene Network.ZNF281 contributes to the DNA damage response by controlling the expression of XRCC2 and XRCC4.Genomic analysis-integrated whole-exome sequencing of neuroblastomas identifies genetic mutations in axon guidance pathway.Overcoming intratumor heterogeneity of polygenic cancer drug resistance with improved biomarker integrationc-MYC-induced genomic instability.BETting on combination to overcome PARPi resistance.Shp2 regulates migratory behavior and response to EGFR-TKIs through ERK1/2 pathway activation in non-small cell lung cancer cells.BRCA1 alterations with additional defects in DNA damage response genes may confer chemoresistance to BRCA-like breast cancers treated with neoadjuvant chemotherapy.Elevated expression of CCAT2 is associated with poor prognosis in esophageal squamous cell carcinoma.
P2860
Q33682954-CAD54A47-E2F6-4E5B-BC62-88CD4797A3B2Q33717681-71AC76C1-E879-46DB-9912-B977328DD7BDQ33836799-3E255C8D-4EF8-4F1F-BA23-49AFA59707FFQ34393817-D42C0477-6A25-4A4C-BD11-D22F8AE5757DQ34990194-316AB9F9-D69F-47C4-9EC6-421AB9D95CBDQ35059927-988BEBD3-564C-4F9D-B139-365A7E4388CEQ35348121-EC096108-595C-431C-A4EF-97349D14E557Q35669806-23AEE66E-6DBC-4B23-9F1B-A5FEA8D97DE0Q35993199-C6FBABDC-E061-44C6-85B0-567805CD2A3FQ36350849-55E6FBBB-C4E7-46A8-9FE8-56241ADA7F02Q36413959-05419FB9-DD8D-487C-9372-BAEA128A2EBAQ36769238-6AE88C8A-2A56-4AD5-9AC6-2CAE7B0F70C3Q37448116-667D64E3-3715-43ED-B15E-95CD3CD0F79CQ38866757-749238A7-707A-4161-9A3D-E733EAE7660AQ39453653-D33F7302-CECD-4929-92FD-B993D7336C14Q40614989-EEFF2A7C-A79E-42A9-96DC-6C2A84123149Q41345228-30A69F29-14C7-4A61-8FFC-73EA675F6786Q41879186-7A1AE5EF-8C48-410A-8F92-59F5C9BA0127Q42127661-19C499AB-35BF-4C1A-A9FE-F0123A7A4A31Q47093793-0570239C-2FD7-46EE-B1EE-087CCF677B7AQ47093822-1A768097-5C49-4BED-9B0D-0A27A4F9ECB3Q48309954-19A8BCB1-2B1B-4E76-8DB5-8D4F066EEED6Q53526654-F31EB09A-1681-4B26-8161-38C7BDB9353D
P2860
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
c-Myc suppression of DNA double-strand break repair.
@ast
c-Myc suppression of DNA double-strand break repair.
@en
type
label
c-Myc suppression of DNA double-strand break repair.
@ast
c-Myc suppression of DNA double-strand break repair.
@en
prefLabel
c-Myc suppression of DNA double-strand break repair.
@ast
c-Myc suppression of DNA double-strand break repair.
@en
P2093
P2860
P356
P1433
P1476
c-Myc suppression of DNA double-strand break repair.
@en
P2093
Fadlo R Khuri
Paul W Doetsch
Shi-Yong Sun
Suresh S Ramalingam
Taofeek K Owonikoko
Walter J Curran
Xingming Deng
Zhaozhong Li
Zhi-Qiang Xiao
P2860
P304
P356
10.1593/NEO.121258
P577
2012-12-01T00:00:00Z